1,098,139 Shares in UiPath, Inc. $PATH Bought by Invenomic Capital Management LP

Invenomic Capital Management LP bought a new stake in UiPath, Inc. (NYSE:PATH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,098,139 shares of the company’s stock, valued at approximately $14,693,000. Invenomic Capital Management LP owned 0.21% of UiPath at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Twin Peaks Wealth Advisors LLC acquired a new position in UiPath during the second quarter valued at approximately $28,000. Covestor Ltd grew its holdings in shares of UiPath by 17.7% in the 3rd quarter. Covestor Ltd now owns 6,522 shares of the company’s stock valued at $87,000 after buying an additional 981 shares during the period. CX Institutional increased its position in shares of UiPath by 37.4% in the 3rd quarter. CX Institutional now owns 6,888 shares of the company’s stock valued at $92,000 after buying an additional 1,874 shares in the last quarter. Newbridge Financial Services Group Inc. increased its position in shares of UiPath by 1,400.0% in the 3rd quarter. Newbridge Financial Services Group Inc. now owns 7,500 shares of the company’s stock valued at $100,000 after buying an additional 7,000 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB raised its stake in UiPath by 507.0% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 7,502 shares of the company’s stock worth $100,000 after buying an additional 6,266 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Stock Performance

PATH opened at $11.58 on Monday. The business’s 50-day simple moving average is $12.97 and its 200 day simple moving average is $14.02. UiPath, Inc. has a 52-week low of $9.38 and a 52-week high of $19.84. The firm has a market capitalization of $6.19 billion, a PE ratio of 22.27, a PEG ratio of 2.18 and a beta of 1.09.

UiPath (NYSE:PATH) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. UiPath had a return on equity of 5.69% and a net margin of 17.53%.The firm had revenue of $481.11 million during the quarter, compared to the consensus estimate of $464.81 million. During the same period last year, the company earned $0.26 earnings per share. The business’s revenue was up 13.4% compared to the same quarter last year. On average, research analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $17.32, for a total value of $779,400.00. Following the completion of the transaction, the chief executive officer owned 28,253,585 shares of the company’s stock, valued at $489,352,092.20. This trade represents a 0.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Ashim Gupta sold 67,468 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the transaction, the chief financial officer owned 557,028 shares in the company, valued at $8,968,150.80. This represents a 10.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 742,468 shares of company stock worth $12,083,785. 23.19% of the stock is owned by corporate insiders.

Analyst Ratings Changes

PATH has been the subject of a number of research analyst reports. Royal Bank Of Canada set a $14.00 target price on UiPath in a research note on Wednesday, February 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of UiPath in a report on Monday, December 29th. BMO Capital Markets reiterated a “market perform” rating on shares of UiPath in a research report on Friday. Canaccord Genuity Group lowered their target price on UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday. Finally, William Blair restated a “hold” rating on shares of UiPath in a report on Thursday. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, UiPath presently has an average rating of “Hold” and a consensus target price of $14.27.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.